GPX4 and cancer: Direct inactivation of GPX4 has been shown to drive ferroptosis independent of intracellular cysteine and GSH levels.13 Thus, numerous studies have focused on identifying novel activators of ferroptosis by targeting GPX4 in order to develop new cancer therapeutics.